高级检索
    刘叙仪, 李文瑜, 杨衿记. Paclitaxel或Docetaxel每周疗法与常规方案在治疗晚期非小细胞肺癌中的差异[J]. 循证医学, 2004, 4(4): 206-209. DOI: 10.3969/j.issn.1671-5144.2004.04.005
    引用本文: 刘叙仪, 李文瑜, 杨衿记. Paclitaxel或Docetaxel每周疗法与常规方案在治疗晚期非小细胞肺癌中的差异[J]. 循证医学, 2004, 4(4): 206-209. DOI: 10.3969/j.issn.1671-5144.2004.04.005
    shu
    The different efficacy between weekly and every-3-week Paclitaxel or Docetaxel in treatment of advanced non-small-cell lung cancer patients[J]. Journal of Evidence-Based Medicine, 2004, 4(4): 206-209. DOI: 10.3969/j.issn.1671-5144.2004.04.005
    Citation: The different efficacy between weekly and every-3-week Paclitaxel or Docetaxel in treatment of advanced non-small-cell lung cancer patients[J]. Journal of Evidence-Based Medicine, 2004, 4(4): 206-209. DOI: 10.3969/j.issn.1671-5144.2004.04.005
    shu

    Paclitaxel或Docetaxel每周疗法与常规方案在治疗晚期非小细胞肺癌中的差异

    The different efficacy between weekly and every-3-week Paclitaxel or Docetaxel in treatment of advanced non-small-cell lung cancer patients

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回